Evaluation parameters | Study Groups | |||||||
---|---|---|---|---|---|---|---|---|
Disease control | Positive control | DSL-LD (P) | DSL-HD (P) | DIL LD (P) | DIL HD (P) | DSL HD (T) | DIL HD (T) | |
Percent alleviative effect | ||||||||
Haematalogical parameters | ||||||||
 RBCs (×106)/μl | 4.33 ± 0.065 | 41.80 ± 2.20a | 32.90 ± 1.65c | 38.71 ± 1.92ab | 35.64 ± 0.85bc | 39.66 ± 1.51ab | 23.79 ± 1.62d | 32.74 ± 1.88c |
 WBCs (×103) /μl | 7.78 ± 0.012 | 50.53 ± 0.87b | 53.54 ± 0.33a | 52.14 ± %0.49a | 50.39 ± 0.35b | 48.46 ± 0.15c | 45.67 ± 0.57d | 45.28 ± 0.46d |
 Platelets (×103)/μl | 344 ± 3.19 | 44.08 ± 0.79e | 56.42 ± 0.58b | 61.81 ± 0.75a | 52.37 ± 0.89c | 58.15 ± 0.76b | 49.76 ± 0.58d | 45.25 ± 0.86e |
Endogenous antioxidant enzymes | ||||||||
 CAT (U/min) | 0.5 ± 0.04 | 342.67 ± 8.33b | 84.67 ± 15.53d | 100 ± 1.20d | 274 ± 12.49c | 285.3 ± 27.15c | 315.3 ± 17.47bc | 410 ± 30.27a |
 POD (U/min) | 1 ± 0.04 | 209 ± 6.56b | 70.33 ± 2.52e | 122 ± 1.73d | 63.33 ± 4.16e | 317.67 ± 3.21a | 183.67 ± 9.07c | 301 ± 10.15a |
 SOD (U/mg protein) | 0.96 ± 0.05 | 261.81 ± 3.66a | 154.17 ± 2.08e | 198.96 ± 4.17c | 190.63 ± 2.08cd | 232.29 ± 3.76b | 176.7 ± 10.43d | 191.6 ± 10.26cd |
 GST (nM/min/ml) | 81.01 ± 0.44 | 191 ± 1.81b | 33.72 ± 0.78e | 99.22 ± 0.87c | 34.43 ± 1.28e | 266.29 ± 1.98a | 67.07 ± 0.78d | 101.08 ± 1.91c |
Biochemical parameters | ||||||||
 ALT (U/L) | 93.20 ± 2.64 | 50.67 ± 2.01b | 50.83 ± 2.45b | 54.36 ± 1.92ab | 52.47 ± 1.78ab | 56.96 ± 2.43a | 58.13 ± 2.10a | 57.46 ± 1.70a |
 AST (U/L) | 67.80 ± 2.05 | 59.73 ± 0.94bc | 65.23 ± 1.50a | 61.91 ± 1.27ab | 54.72 ± 1.89de | 58.58 ± 1.39bcd | 56.96 ± 1.01cde | 53.79 ± 1.69e |
 ALP (U/L) | 356 ± 5.69 | 60.69 ± 1.01bcd | 58.38 ± 0.92de | 61.14 ± 1.14abc | 57.28 ± 0.81e | 59.43 ± 0.35cde | 62.15 ± 1.01ab | 63.38 ± 1.13a |
 Urea (mg/dl) | 72.2 ± 2.76 | 62.59 ± 1.41a | 51.01 ± 1.37c | 57.02 ± 2.44ab | 50.15 ± 1.18c | 52.29 ± 1.71bc | 61.52 ± 2.84a | 59.65 ± 2.60a |
 Creatinine (mg/dl) | 2.89 ± 0.45 | 61.01 ± 5.04a | 60.21 ± 3.34a | 61.82 ± 4.19a | 60.32 ± 3.89a | 62.40 ± 2.78a | 61.25 ± 3.51a | 61.94 ± 2.50a |
 Bilirubin (mg/ml) | 7.56 ± 0.97 | 65.21 ± 2.82a | 58.38 ± 1.23a | 63.10 ± 8.54a | 59.79 ± 4.37a | 60.76 ± 3.44a | 68.17 ± 1.07a | 68.08 ± 5.16a |
 Total proteins (g/dl) | 2.14 ± 0.11 | 214.02 ± 18.19a | 185.51 ± 23.36a | 224.45 ± 27.63a | 213.55 ± 29.55a | 210.28 ± 23.22a | 186.29 ± 17.50a | 195.02 ± 19.61a |
Lipid peroxidation assay | ||||||||
 TBARs (nM/min/mg protein) | 133.7 ± 2.61 | 35.74 ± 0.82a | 15.08 ± 1.65d | 24.27 ± 1.11c | 15.12 ± 1.74d | 21.39 ± 1.22c | 37.41 ± 0.89a | 31.01 ± 1.32b |